Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 103

1.

Polymorphisms of the glucose transporter (GLUT1) gene are associated with diabetic nephropathy.

Hodgkinson AD, Millward BA, Demaine AG.

Kidney Int. 2001 Mar;59(3):985-9.

2.

[Insulin receptor substrate-1 and glucose transporter gene polymorphisms in noninsulin-dependent diabetes mellitus].

Liu Z, Guan T, Chen Z.

Zhonghua Yi Xue Za Zhi. 1998 Sep;78(9):662-5. Chinese.

PMID:
11038788
3.
4.
5.

Polymorphisms of the aldose reductase gene and susceptibility to retinopathy in type 1 diabetes mellitus.

Demaine A, Cross D, Millward A.

Invest Ophthalmol Vis Sci. 2000 Dec;41(13):4064-8.

PMID:
11095596
6.
7.

Dinucleotide repeat polymorphism of matrix metalloproteinase-9 gene is associated with diabetic nephropathy.

Maeda S, Haneda M, Guo B, Koya D, Hayashi K, Sugimoto T, Isshiki K, Yasuda H, Kashiwagi A, Kikkawa R.

Kidney Int. 2001 Oct;60(4):1428-34.

8.

[Polymorphism of aldose reductase gene and susceptibility to retinopathy and nephropathy in Caucasians with type 1 diabetes].

Fanelli A, Hadjadj S, Gallois Y, Fumeron F, Betoule D, Grandchamp B, Marre M.

Arch Mal Coeur Vaiss. 2002 Jul-Aug;95(7-8):701-8. French.

PMID:
12365083
9.

Role of GLUT1 gene in susceptibility to diabetic nephropathy in type 2 diabetes.

Grzeszczak W, Moczulski DK, Zychma M, Zukowska-Szczechowska E, Trautsolt W, Szydlowska I.

Kidney Int. 2001 Feb;59(2):631-6.

10.

Polymorphisms of the vascular endothelial growth factor and susceptibility to diabetic microvascular complications in patients with type 1 diabetes mellitus.

Yang B, Cross DF, Ollerenshaw M, Millward BA, Demaine AG.

J Diabetes Complications. 2003 Jan-Feb;17(1):1-6.

PMID:
12505748
11.

Phenotypic heterogeneity and associations of two aldose reductase gene polymorphisms with nephropathy and retinopathy in type 2 diabetes.

Wang Y, Ng MC, Lee SC, So WY, Tong PC, Cockram CS, Critchley JA, Chan JC.

Diabetes Care. 2003 Aug;26(8):2410-5.

PMID:
12882871
12.
13.

XbaI GLUT1 gene polymorphism and the risk of type 2 diabetes with nephropathy.

Stefanidis I, Kytoudis K, Papathanasiou AA, Zaragotas D, Melistas L, Kitsios GD, Yiannakouris N, Zintzaras E.

Dis Markers. 2009;27(1):29-35. doi: 10.3233/DMA-2009-0648.

14.

[The association between polymorphism of endothelial nitric oxide synthase gene and diabetic nephropathy].

Li C, Dong Y, Lü W.

Zhonghua Nei Ke Za Zhi. 2001 Nov;40(11):729-32. Chinese.

PMID:
11930675
15.

Aldose reductase gene polymorphism is associated with progression of diabetic nephropathy in Japanese patients with type 1 diabetes mellitus.

Yamamoto T, Sato T, Hosoi M, Yoshioka K, Tanaka S, Tahara H, Nishizawa Y, Fujii S.

Diabetes Obes Metab. 2003 Jan;5(1):51-7.

PMID:
12542725
16.

(AC)(n) polymorphism of aldose reductase gene and diabetic microvascular complications in type 2 diabetes mellitus.

Park HK, Ahn CW, Lee GT, Kim SJ, Song YD, Lim SK, Kim KR, Huh KB, Lee HC.

Diabetes Res Clin Pract. 2002 Feb;55(2):151-7.

PMID:
11796181
17.

Z-2 microsatellite allele is linked to increased expression of the aldose reductase gene in diabetic nephropathy.

Shah VO, Scavini M, Nikolic J, Sun Y, Vai S, Griffith JK, Dorin RI, Stidley C, Yacoub M, Vander Jagt DL, Eaton RP, Zager PG.

J Clin Endocrinol Metab. 1998 Aug;83(8):2886-91.

PMID:
9709964
19.
20.

Association of aldose reductase gene Z+2 polymorphism with reduced susceptibility to diabetic nephropathy in Caucasian Type 1 diabetic patients.

Lajer M, Tarnow L, Fleckner J, Hansen BV, Edwards DG, Parving HH, Boel E.

Diabet Med. 2004 Aug;21(8):867-73.

PMID:
15270790

Supplemental Content

Support Center